HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effect of genetic factors on the response to vitamin D3 supplementation in the VIDARIS randomized controlled trial.

AbstractOBJECTIVES:
Supplementation provides the best means of improving vitamin D status; however, individual responses vary partly owing to genetics. The aim of this study was to determine whether 28 single nucleotide polymorphisms (SNPs) in six key vitamin D pathway genes (GC, DHCR7, CYP2 R1, CYP24 A1, CYP27 B1, VDR) were associated with differences in response to supplementation.
METHODS:
Participants (N = 313; n = 160 vitamin D, n = 153 placebo) were part of VIDARIS (Vitamin D and Acute Respiratory Infections Study), a double-blind, randomized controlled trial involving oral monthly supplementation of either vitamin D3 (200 000 IU each for the first 2 mo, thereafter 100 000 IU monthly) or placebo for 18 mo. Circulating 25-hydroxyvitamin D (25[OH]D) concentrations at baseline and 2, 6, 12, and 18 mo, and vitamin D binding protein (Gc-globulin) and calculated free 25(OH)D concentrations at baseline and 2 mo were obtained. Multiple regression was used to model associations between genetic variants and 25(OH)D, Gc-globulin, and free 25(OH)D concentrations.
RESULTS:
SNPs within GC, CYP2 R1, and CYP27 B1 were associated with 25(OH)D concentrations following supplementation. However, only two GC gene SNPs (rs2282679, rs1155563) were significant after adjustment for multiple testing. This effect disappeared after more than 2 mo of supplementation. None of the SNPs were significantly associated with Gc-globulin concentrations; however, there was a significant interaction with one SNP in DHCR7 (rs12785878), which was associated with reduced free 25(OH)D concentrations in the supplemented arm.
CONCLUSION:
Only variants of GC were associated with 25(OH)D concentrations after supplementation. This effect was modest and disappeared after >2 mo of supplementation, suggesting it may be time/dose-dependent and saturable.
AuthorsSandy Slow, John P Pearson, Christopher M Florkowski, Peter A Elder, John G Lewis, Martin A Kennedy, David R Murdoch
JournalNutrition (Burbank, Los Angeles County, Calif.) (Nutrition) 2020 Jul - Aug Vol. 75-76 Pg. 110761 ISSN: 1873-1244 [Electronic] United States
PMID32289634 (Publication Type: Journal Article, Randomized Controlled Trial)
CopyrightCopyright © 2020 Elsevier Inc. All rights reserved.
Chemical References
  • Vitamin D-Binding Protein
  • Vitamin D
  • Cholecalciferol
Topics
  • Cholecalciferol
  • Dietary Supplements
  • Double-Blind Method
  • Humans
  • Vitamin D
  • Vitamin D Deficiency (drug therapy, genetics)
  • Vitamin D-Binding Protein (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: